Ovarian Cancer News and Research

Latest Ovarian Cancer News and Research

AI tools map tumor architecture to predict treatment response

AI tools map tumor architecture to predict treatment response

Biosimilars reduce financial burden for cancer patients and insurers

Biosimilars reduce financial burden for cancer patients and insurers

Real-world Chinese study confirms benefits of niraparib maintenance therapy for ovarian cancer

Real-world Chinese study confirms benefits of niraparib maintenance therapy for ovarian cancer

Targeting cyclin-dependent kinases offers new pathways for cancer therapy

Targeting cyclin-dependent kinases offers new pathways for cancer therapy

Special journal issue highlights precision prevention in cancer epidemiology

Special journal issue highlights precision prevention in cancer epidemiology

New study links chronic stress to immunotherapy resistance in tumors

New study links chronic stress to immunotherapy resistance in tumors

Neighborhood conditions help explain racial disparities in ovarian cancer survival

Neighborhood conditions help explain racial disparities in ovarian cancer survival

Thinning cancer cells' sugar coating could expose tumors to immune attack

Thinning cancer cells' sugar coating could expose tumors to immune attack

Experimental drug CS18 shows promise for overcoming cancer treatment resistance

Experimental drug CS18 shows promise for overcoming cancer treatment resistance

Breast cancer co-opts the immune system to attract nerves that fuel tumor growth

Breast cancer co-opts the immune system to attract nerves that fuel tumor growth

Study links dietary fructose to aggressive spread of ovarian cancer

Study links dietary fructose to aggressive spread of ovarian cancer

Immature NK cells in donor cord blood can undermine CAR NK cell therapy activity

Immature NK cells in donor cord blood can undermine CAR NK cell therapy activity

AI model predicts cancer diagnoses up to a year in advance using routine clinical data

AI model predicts cancer diagnoses up to a year in advance using routine clinical data

Phase 3 clinical trial enrolls first platinum-resistant ovarian cancer patient

Phase 3 clinical trial enrolls first platinum-resistant ovarian cancer patient

New mechanism behind chemotherapy resistance in ovarian cancer discovered

New mechanism behind chemotherapy resistance in ovarian cancer discovered

Wistar scientists develop new bispecific T cell engager to target ovarian cancer

Wistar scientists develop new bispecific T cell engager to target ovarian cancer

New generation approaches revive BET protein inhibitors in solid tumors

New generation approaches revive BET protein inhibitors in solid tumors

New form of hereditary prostate cancer can cause aggressive disease at a young age

New form of hereditary prostate cancer can cause aggressive disease at a young age

Emergency admissions associated with advanced ovarian cancer at diagnosis

Emergency admissions associated with advanced ovarian cancer at diagnosis

Estonian study highlights value of early genetic tests to identify hereditary cancer risks

Estonian study highlights value of early genetic tests to identify hereditary cancer risks

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.